Recommendations for the use of albumin and immunoglobulins.
about
The non-immunosuppressive management of childhood nephrotic syndromeReview of the rational use and adverse reactions to human serum albumin in the People's Republic of ChinaUse of intravenous immunoglobulin in pediatric practiceImmunobiology of fibrin-based engineered heart tissueThe Efficacy of Oral Nutritional Intervention in Malnourished Cancer Patients: a Systemic ReviewOverview of Albumin and Its Purification MethodsBeneficial use of immunoglobulins in the treatment of Sydenham chorea.Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative periodRecommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.Immunoglobulin: production, mechanisms of action and formulations.Implementation of Pharmaceutical Practice Guidelines by a Project Model Based: Clinical and Economic Impact.Liver transplantation: Advances and perioperative care.The half-life of infusion fluids: An educational reviewCross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - RevisedThe evaluation of albumin utilization in a teaching university hospital in iran.Clinical use of albumin.The demand for human albumin in ItalyThe demand for polyvalent immunoglobulins in Italy.The clinical use of albumin: the point of view of a specialist in intensive care.Albumin: physiologic and clinical effects on lung function.Clinical use of polyvalent immunoglobulinsKey Controversies in Colloid and Crystalloid Fluid Utilization.Effectiveness and Safety of Polygeline in Patients with Hypovolemia due to Trauma.Investigating the Use of Human Albumin in a Non-Teaching Hospital in IranTransfusion therapy in the peri-operative periodThe clinical use of albumin: a topic for Transfusion Medicine.Prioritization of evidence-based indications for intravenous immunoglobulin.Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?Transplantation of hepatocytes from genetically engineered pigs into baboons.Extended Half-Life Factor VIII and Factor IX Preparations.
P2860
Q26778157-2309556F-44D4-4C0D-83A3-07C28DE20EE4Q27001514-CD98B63B-0C5C-470F-8240-77AE499E1022Q27011481-8179F5F3-A1F1-4CB3-88E0-64D893D68C2BQ27301288-ABF702B2-0CCF-4A64-98B1-0D9FC5A381BBQ28068895-DC906BE5-F9B3-4C88-9998-E724D0205230Q28468555-776B5162-222B-49FC-B68D-58D782CF807DQ34013487-BC42AAB2-D20F-4B01-B48A-C04BA7A74FB7Q34988663-FA830CE2-06B4-496B-82F9-7566E743863FQ35049179-24BEDA76-054B-4A3B-B3F5-44FFB4984568Q36153609-2D994BBE-75C8-42C7-98A9-4A445D58A863Q36206811-69E754DF-5E33-44F8-A3A6-1E5ADB5C6306Q36313395-4FA6A18F-AA10-4D5A-A2A1-46FC0ACBFCDCQ36961846-85423680-8FDD-43F3-85BE-8B7510C84E54Q37045780-0F163E0B-9A37-40B1-ADEF-FBDDF20C7B01Q37310770-9BF2F77C-D4D8-4B29-B65B-B4205E01F0FBQ37370312-247F45C1-F6C1-462A-96FB-D8CD69C06CD6Q37370326-00FCAEA3-24C0-4B3B-90C6-FF9149A117B7Q37370331-FC7FE931-6793-43D5-8B2A-F1C64884921CQ37655011-939A83C9-F855-4B8F-8A8F-638B37D4C74BQ38118051-11CFC683-5164-4101-AE0A-7DA007F787BDQ38170872-E6CA5AE6-E8B4-477A-ACA1-88B426B7E2F4Q38592705-24E35748-A3A8-4720-8A83-D2EA54DD57E4Q41480931-C898499D-E1E9-4AE4-ABA9-D59DC8FF2009Q41903603-9F478565-A0C9-4E61-98B6-8A86CBD6A095Q42572431-2A4D0DA9-397B-406B-8082-95C4F7D92452Q42668212-0910DE95-0E0D-4C23-AB76-CA09ECCD72C2Q43103915-D3B450F9-243A-484D-8846-99E317FFB386Q43240422-53AC3910-E19A-4291-9FEE-1BDB03B3651CQ48301685-615C8F3F-B320-4146-8555-7B0FEC8D0C7CQ55025596-3BBA3BC2-1C14-4E96-BC8D-BEBE1B45271E
P2860
Recommendations for the use of albumin and immunoglobulins.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Recommendations for the use of albumin and immunoglobulins.
@en
Recommendations for the use of albumin and immunoglobulins.
@nl
type
label
Recommendations for the use of albumin and immunoglobulins.
@en
Recommendations for the use of albumin and immunoglobulins.
@nl
prefLabel
Recommendations for the use of albumin and immunoglobulins.
@en
Recommendations for the use of albumin and immunoglobulins.
@nl
P2093
P2860
P356
P1476
Recommendations for the use of albumin and immunoglobulins.
@en
P2093
Angela Lattanzio
Francesco Bennardello
Giancarlo Maria Liumbruno
Gina Rossettias
Italian Society of Transfusion Medicine and Immunohaematology (SIMTI)
Pierluigi Piccoli
P2860
P304
P356
10.2450/2009.0094-09
P577
2009-07-01T00:00:00Z